相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of Fluconazole, Amphotericin B, and Caspofungin on Candida albicans Biofilms under Conditions of Flow and on Biofilm Dispersion
Priya Uppuluri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vitro Activities of Anidulafungin and Other Antifungal Agents against Biofilms Formed by Clinical Isolates of Different Candida and Aspergillus Species
Barbara Fiori et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vivo Efficacy of Anidulafungin against Mature Candida albicans Biofilms in a Novel Rat Model of Catheter-Associated Candidiasis
Sona Kucharikova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study
Marya D. Zilberberg et al.
BMC INFECTIOUS DISEASES (2010)
Cost and Resource Utilization Associated With Fluconazole as First-Line Therapy for Invasive Candidiasis: A Retrospective Database Analysis
Christopher W. Craver et al.
CLINICAL THERAPEUTICS (2010)
Hydrolytic Enzyme Production is Associated with Candida Albicans Biofilm Formation from Patients with Type 1 Diabetes
Ranjith Rajendran et al.
MYCOPATHOLOGIA (2010)
Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
Priya Uppuluri et al.
PLOS PATHOGENS (2010)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)
Olivier Leroy et al.
CRITICAL CARE MEDICINE (2009)
Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis
Anna L. Lazzell et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Characteristics of Candida albicans Biofilms Grown in a Synthetic Urine Medium
Priya Uppuluri et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Parenteral Lipid Emulsion Induces Germination of Candida albicans and Increases Biofilm Formation on Medical Catheter Surfaces
Kim Swindell et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Time Course Global Gene Expression Analysis of an In Vivo Candida Biofilm
Jeniel E. Nett et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Biofilm formation in clinical Candida isolates and its association with virulence
Fahmi Hasan et al.
MICROBES AND INFECTION (2009)
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
Christopher G. Pierce et al.
NATURE PROTOCOLS (2008)
Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections
David L. Horn et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals
Matteo Bassetti et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia
Mario Tumbarello et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Candida biofilms on implanted biomaterials:: a clinically significant problem
Gordon Ramage et al.
FEMS YEAST RESEARCH (2006)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis
TE Zaoutis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance
J Morgan et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Candida infections of medical devices
EM Kojic et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Development and characterization of an in vivo central venous catheter Candida albicans biofilm model
D Andes et al.
INFECTION AND IMMUNITY (2004)
Candida biofilm resistance
PK Mukherjee et al.
DRUG RESISTANCE UPDATES (2004)
Candida parapsilosis characterization in an outbreak setting
DM Kuhn et al.
EMERGING INFECTIOUS DISEASES (2004)
Candida biofilms and their role in infection
LJ Douglas
TRENDS IN MICROBIOLOGY (2003)
Guidelines for the prevention of intravascular catheter-related infections
NP O'Grady et al.
PEDIATRICS (2002)
Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins
DM Kuhn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Biofilm production by isolates of Candida species recovered from nonneutropenic patients:: Comparison of bloodstream isolates with isolates from other sources
JH Shin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Engineering out the risk for infection with urinary catheters
DG Maki et al.
EMERGING INFECTIOUS DISEASES (2001)